The impact of COVID-19 on subthreshold depressive symptoms: a longitudinal study
Open Access
- 15 February 2021
- journal article
- research article
- Published by Cambridge University Press (CUP) in Epidemiology and Psychiatric Sciences
- Vol. 30, 1-29
- https://doi.org/10.1017/s2045796021000044
Abstract
Aims The coronavirus disease 2019 (COVID-19) pandemic represents an unprecedented threat to mental health. Herein, we assessed the impact of COVID-19 on subthreshold depressive symptoms and identified potential mitigating factors. Methods Participants were from Depression Cohort in China (ChiCTR registry number 1900022145). Adults (n = 1722) with subthreshold depressive symptoms were enrolled between March and October 2019 in a 6-month, community-based interventional study that aimed to prevent clinical depression using psychoeducation. A total of 1506 participants completed the study in Shenzhen, China: 726 participants, who completed the study between March 2019 and January 2020 (i.e. before COVID-19), comprised the 'wave 1' group; 780 participants, who were enrolled before COVID-19 and completed the 6-month endpoint assessment during COVID-19, comprised 'wave 2'. Symptoms of depression, anxiety and insomnia were assessed at baseline and endpoint (i.e. 6-month follow-up) using the Patient Health Questionnaire-9 (PHQ-9), Generalised Anxiety Disorder-7 (GAD-7) and Insomnia Severity Index (ISI), respectively. Measures of resilience and regular exercise were assessed at baseline. We compared the mental health outcomes between wave 1 and wave 2 groups. We additionally investigated how mental health outcomes changed across disparate stages of the COVID-19 pandemic in China, i.e. peak (7-13 February), post-peak (14-27 February), remission plateau (28 February-present). Results COVID-19 increased the risk for three mental outcomes: (1) depression (odds ratio [OR] = 1.30, 95% confidence interval [CI]: 1.04-1.62); (2) anxiety (OR = 1.47, 95% CI: 1.16-1.88) and (3) insomnia (OR = 1.37, 95% CI: 1.07-1.77). The highest proportion of probable depression and anxiety was observed post-peak, with 52.9% and 41.4%, respectively. Greater baseline resilience scores had a protective effect on the three main outcomes (depression: OR = 0.26, 95% CI: 0.19-0.37; anxiety: OR = 1.22, 95% CI: 0.14-0.33 and insomnia: OR = 0.18, 95% CI: 0.11-0.28). Furthermore, regular physical activity mitigated the risk for depression (OR = 0.79, 95% CI: 0.79-0.99). Conclusions The COVID-19 pandemic exerted a highly significant and negative impact on symptoms of depression, anxiety and insomnia. Mental health outcomes fluctuated as a function of the duration of the pandemic and were alleviated to some extent with the observed decline in community-based transmission. Augmenting resiliency and regular exercise provide an opportunity to mitigate the risk for mental health symptoms during this severe public health crisis.Keywords
This publication has 36 references indexed in Scilit:
- Definitions and factors associated with subthreshold depressive conditions: a systematic reviewBMC Psychiatry, 2012
- Prevalence of psychiatric morbidity and psychological adaptation of the nurses in a structured SARS caring unit during outbreak: A prospective and periodic assessment study in TaiwanJournal of Psychiatric Research, 2007
- FACTOR ANALYSIS AND PSYCHOMETRIC EVALUATION OF THE CONNOR-DAVIDSON RESILIENCE SCALE (CD-RISC) WITH CHINESE PEOPLESocial Behavior and Personality: an international journal, 2007
- Does the Association Between Alcohol Consumption and Depression Depend on How They Are Measured?Alcohol: Clinical and Experimental Research, 2006
- Stress and DepressionAnnual Review of Clinical Psychology, 2005
- Subthreshold depression as a risk indicator for major depressive disorder: a systematic review of prospective studiesActa Psychiatrica Scandinavica, 2004
- Development of a new resilience scale: The Connor-Davidson Resilience Scale (CD-RISC)Depression and Anxiety, 2003
- The PHQ-9Journal of General Internal Medicine, 2001
- Validation of the Insomnia Severity Index as an outcome measure for insomnia researchSleep Medicine, 2001
- Empirical Examination of Current Depression Categories in a Population-Based Study: Symptoms, Course, and Risk FactorsAmerican Journal of Psychiatry, 2000